Detail akcie Tek Life Sc Inv-SBI online

Business Summary: abrdn Life Sciences Investors (the Fund) is a non-diversified closed-end management investment company. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in securities of life sciences companies. The Fund invests primarily in securities of public and private companies. The Fund may invest up to 20% of its net assets in securities of foreign issuers, expected to be located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded primarily in foreign markets. The Fund’s investment adviser is abrdn Inc.
Financial Summary: BRIEF: For the fiscal year ended 30 September 2024, abrdn Life Sciences Investors revenues increased 14% to $4M. Net income increased from $22.4M to $85.3M. Revenues reflect Dividend income increase of 1% to $2.9M. Net income benefited from Investments in affiliated issuers increase from $15.3M (expense) to $50M (income), Unrealized G/L on Investment Securitie- increase of 30% to $5.2M (income). Dividend per share totaled to $1.66.